Clinical Trial Update: Pilot Study of Pulmozyme (rhDNase) in Patients With Head and Neck Cancers Treated With Radiation Therapy + Chemotherapy [EARLY_Phase 1]

View source ↗

Summary

An early-phase pilot study evaluating Pulmozyme (dornase alfa) in patients with head and neck cancer treated with radiation therapy and chemotherapy; no results…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Head and Neck Cancer

Drugs mentioned

• Pulmozyme (dornase alfa)

Snippet

Sponsor: Northwestern University | Conditions: Head and Neck Cancer | EARLY_Phase 1 | Status: UNKNOWN